Onelife Capital Extends ₹36 Crore Rights Issue to March 16

Introduction

Onelife Capital Advisors Limited has extended the closing date of its ongoing rights issue, a move designed to provide eligible shareholders with more time to participate. The Right Issue Committee of the Board of Directors approved the extension in a meeting on March 2, 2026. The closing date was moved from March 6, 2026, to March 16, 2026. This decision underscores the company's effort to ensure maximum participation in its ₹36 crore capital-raising initiative.

Details of the Extension

The committee's decision not only pushed back the issue's closing date but also revised the last date for on-market renunciation of rights entitlements to March 10, 2026. The company confirmed that all other terms and conditions outlined in the Letter of Offer dated February 10, 2026, remain unchanged. The extension aims to accommodate shareholders and provide a wider window for application submissions, ensuring the successful completion of the capital raise.

Overview of the Rights Issue

The rights issue was structured to raise ₹36 crore through the issuance of 2,40,00,000 fully paid-up equity shares. The issue was priced at ₹15 per share, which includes a face value of ₹10 and a premium of ₹5 per share. The entitlement ratio was set at 300 rights equity shares for every 167 existing equity shares held by eligible shareholders as of the record date, February 16, 2026. This structure offered a significant opportunity for existing investors to increase their stake in the company.

Revised Timeline and Key Dates

Following the extension, the timeline for the rights issue was adjusted. The issue, which originally opened on February 23, 2026, concluded on the new date of March 16, 2026. The record date for determining shareholder eligibility remained February 16, 2026. The successful allotment of shares was subsequently completed on March 17, 2026, marking the formal conclusion of the process.

Purpose of the Capital Raise

The net proceeds from the ₹36 crore rights issue are earmarked for specific strategic objectives. The primary goal is to strengthen the company's financial base and support its subsidiary. A significant portion, ₹27 crore, will be invested in its subsidiary, Dealmoney Commodities Private Limited, to fund its margin money requirements. The remaining ₹8.64 crore is allocated for general corporate purposes, providing operational flexibility and supporting future growth initiatives.

Impact on Share Capital

The successful completion and allotment of the rights issue have significantly altered the company's capital structure. The allotment of 2,40,00,000 new equity shares increased Onelife Capital Advisors' paid-up equity share capital from ₹13,36,00,000 to ₹37,36,00,000. Consequently, the total number of outstanding equity shares rose from 1,33,60,000 to 3,73,60,000. This expansion of the equity base reflects the infusion of fresh capital and strengthens the company's balance sheet.

Shareholder Participation and Documentation

Eligible shareholders could apply for the rights issue through various channels, including online ASBA (Applications Supported by Blocked Amount) via net banking or by submitting a physical application form. The full issue price of ₹15 per share was payable upon application. All necessary documents, including the Letter of Offer, were made available on the websites of the company, the registrar (KFin Technologies Limited), and the stock exchanges (BSE and NSE).

Conclusion

Onelife Capital Advisors successfully navigated its ₹36 crore rights issue, adapting its timeline to maximize shareholder participation. The extension of the closing date to March 16, 2026, proved effective, leading to the full subscription and allotment of shares by March 17, 2026. The capital raised will be instrumental in funding its subsidiary's requirements and supporting general corporate activities, positioning the company for its next phase of growth.